DIVERSA will be attending BIO-Europe 2026, taking place from November 9–11 at Koelnmesse in Cologne, Germany.
Representing our team will be Abi Vázquez, PhD, Co-Founder & COO, and Lara Touza, PhD, Project & Operations Associate.
BIO-Europe brings together biotech and pharmaceutical companies, investors and partners from across the global life sciences ecosystem, making it an important opportunity for DIVERSA to strengthen existing relationships and explore new collaborations.
Advanced drug delivery through lipid-based nanotechnology
At DIVERSA, we develop lipid-based nanosystems for the formulation, protection and delivery of complex therapeutic molecules.
Our technologies and development capabilities span:
- RNA and nucleic acid delivery
- DNA and oligonucleotides
- Proteins and peptides
- Small-molecule encapsulation
- Lipid nanoparticle development and optimization
- Tailored formulation development
Our approach combines proprietary lipid technologies with formulation expertise to adapt the delivery strategy to the characteristics and challenges of each molecule.
Partnering at BIO-Europe
For DIVERSA, BIO-Europe is especially valuable as a place to discuss projects at different stages of development and identify opportunities for technology evaluation, co-development and strategic partnerships.
Abi and Lara will be available throughout the event to meet companies working on new therapeutic modalities, complex molecules and formulation challenges, as well as organizations interested in evaluating new lipid-based delivery technologies.
Whether you are looking for a delivery strategy for a new asset, facing formulation or stability challenges, or exploring potential technology partnerships, we would be happy to learn more about your project.
Meet us in Cologne
📍 BIO-Europe 2026 – Koelnmesse, Cologne, Germany
📅 November 9–11, 2026
If you are attending BIO-Europe, get in touch with our team or send us a meeting request through the partnering platform.
We look forward to connecting with partners from across the global biotech ecosystem and exploring new opportunities in Cologne.
